HomeInsightsResults

Concord Drugs Ltd Quarterly Result

Concord Drugs Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

2.0 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

Net Profit

₹ 0.04

Last updated on: Dec 12, 2024

Key Highlights

  • The revenue of Concord Drugs Ltd for the Sep '24 is ₹ 12.37 crore as compare to the Jun '24 revenue of ₹ 11.69 crore. This represent the growth of 5.8169403%.
  • The ebitda of Concord Drugs Ltd for the Sep '24 is ₹ 0.88 crore as compare to the Jun '24 ebitda of ₹ 0.83 crore. This represent the growth of 6.0240974%.
  • The net profit of Concord Drugs Ltd for the Sep '24 is ₹ 0.04 crore as compare to the Jun '24 net profit of ₹ 0.03 crore. This represent the growth of 33.333336%.

Results Analysis

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202436.87
10 Dec 202437.71
09 Dec 202437.98
06 Dec 202437.86
05 Dec 202438.01
04 Dec 202438.23
03 Dec 202437.34
02 Dec 202435
29 Nov 202435
28 Nov 202435.35

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Concord Drugs Ltd News Hub

News

Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November ...

Read more

08 Nov 2024 12:33

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 17:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 10:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 2024 11:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 2024 16:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 2024 11:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Concord Drugs Ltd

What key financial metrics are included in Concord Drugs Ltd's quarterly results?

Key financial metrics in Concord Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Concord Drugs Ltd announce its quarterly results?

Concord Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Concord Drugs Ltd's quarterly performance impact its stock price?

Concord Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Concord Drugs Ltd's quarterly results on dividends?

The impact of Concord Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Concord Drugs Ltd's quarterly results?

Yes, Concord Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions